Presentations & Events

2017 November 6 – 8

Meet Oncology Venture at Bio-Europe Partnering Conference, Berlin.

Contact: VP Business Development, Claus Deichgræber
Mobile: +45 2015 0605
E-mail: cd@oncologyventure.com

2017 September 19

Meet Oncology Venture at
Dansk Aktionærforening -Investordagen, at Radisson Blu, Copenhagen  

Contact: CFO Nikolaj Buhl Jensen 
Mobile: +45 2678 2520
E-mail: nbj@oncologyventure.com

2017 September 13 – 14

Meet Oncology Venture at NLS-Days, 
Malmö, Sweden.

Contact: VP Business Development, Claus Deichgræber
Mobile: +45 2015 0605
E-mail: cd@oncologyventure.com

2017 June 2 – 6

Meet Oncology Venture at ASCO
Annual Meeting, Chicago, Illinois

Contact: VP Business Development, Claus Deichgræber
Mobile: +45 2015 0605
E-mail: cd@oncologyventure.com

 

2017 June 2

Meet Oncology Venture at SACHS,
Annual Immuno-Oncology BD&L and Investment Forum, Chicago, 
Illinois

Contact: VP Business Development, Claus Deichgræber
Mobile: +45 2015 0605
E-mail: cd@oncologyventure.com

 

2017 May 23 – 25

Meet Oncology Venture at IATI BioMed,
Tel Aviv, Israel

Contact: VP Business Development, Claus Deichgræber
Mobile: +45 2015 0605
E-mail: cd@oncologyventure.com

 

 

2017 May 3 – 4

Meet Oncology Venture at NSGO
Annual Meeting, Helsinki, Finland

Contact: VP Clinical Operations, Annie Rasmussen
Mobile: +45 2338 3927
E-mail: ar@oncologyventure.com

 

2017 March 20 – 22

Meet Oncology Venture at BioEurope  Barcelona, Spain

Contact: VP Business Development, Claus Deichgræber
Mobile: +45 2015 0605
E-mail: cd@oncologyventure.com

 


2017 January 9 – 11

Meet Oncology Venture at BioTech Showcase, San Francisco, US

Contact: CEO, Peter Buhl, Mobile: +45 2160 8922, E-mail: pbj@oncologyventure.com

 


2017 March 23

Meet Oncology Venture at Sedermeradagen in Copenhagen, Denmark

Contact: CEO, Peter Buhl, Mobile: +45 2160 8922, E-mail: pbj@oncologyventure.com

 


2016 November 7-9

Meet Oncology Venture at the Bio-Europe 2016, Cologne, Germany

Contact: VP Business Development, Claus Deichgræber, Mobile: +45 2015 0605, E-mail: cd@oncologyventure.com

English

 

2016 October 7-11

Meet Oncology Venture at the ESMO 2016 Congress, Copenhagen, Denmark

Contact: CCO, Annie Rasmussen, Mobile: +45 2338 3927, E-mail: ar@oncologyventure.com

English

 

2016 September 28

Meet Oncology Venture at Sedermeradagen in Copenhagen, Denmark

Contact: CEO, Peter Buhl, Mobile: +45 2160 8922, E-mail: pbj@oncologyventure.com

 

2016 September 27-28

Meet Oncology Venture at SACHS ASSOCIATES 16th Annual Biotech Forum in Basel, for Global Partnering & Investment

Contact: VP Business Development, Claus Deichgræber, Mobile: +45 2015 0605, E-mail: cd@oncologyventure.com

English

 

2016 September 14-15

Meet Oncology Venture at the Nordic Life Science Days in Stockholm, Sweden

Contact: VP Business Development, Claus Deichgräber, Mobile: +45 2015 0605, E-mail: cd@oncologyventure.com

English

 

2016 June 6-9

Meet Oncology Venture at the 2016 Bio International Convention, San Francisco, USA

Contact: CTO, Thomas Jensen, Mobile +1 602 812 0576, E-mail: tj@oncologyventure.com

 

2016 June 3

Meet Oncology Venture at the 2nd Annual Immuno-Oncology: BD&L Investment Forum, Chicago, USA

Contact: COO, Ulla Hald Buhl, Mobile +45 2170 1049, E-mail: uhb@oncologyventure.com

 

2016 June 2 – 7

Meet Oncology Venture at the ASCO Annual Meeting 2016, Chicago, USA

Contacts: COO, Ulla Hald Buhl, Mobile +45 2170 1049, E-mail: uhb@oncologyventure.com and CCO, Annie Rasmussen, Mobile +45 2338 3927, E-mail: ar@oncologyventure.com

 

2016 June 1

Oncology Venture Sweden AB presents at Sedeermeradagen in Göteborg, Sweden

Contact: COO, Ulla Hald Buhl, Mobile +45 2170 1049, E-mail: uhb@oncologyventure.com

 

2016 May 18-19

Meet Oncology Venture at the ChinaBio Partnering Forum 2016, Suzhou

Contact: VP Corporate Development, James G Cullem, Mobile +1 978 500 0863, E-mail: jgc@oncologyventure.com 

English

 

2016 April 16-20

Meet Oncology Venture at the AACR, New Orleans

Contact: VP Corporate Development, James G Cullem, Mobile +1 978 500 0863, E-mail: jgc@oncologyventure.com 

English

 

2016 April 9

CTO, Thomas H. Jensen gives a TED-talk

English

 

2016 April 4-6

Meet Oncology venture at the Bio-Spring Conference, Stockholm

Contact: VP Business Development, Claus Deichgræber, Mobile: +45 2015 0605, E-mail: cd@oncologyventure.com

English

 

2016 March 15-16

Meet Oncology Venture at the Bio-Asia Conference, Tokyo

Contact: VP Business Development, Claus Deichgræber, Mobile: +45 2015 0605, E-mail: cd@oncologyventure.com

English

 

2016 March 16

Oncology Venture presents at Sedermeradagen

View video presentation

 

2016 March 7

Oncology Venture presents LiPlaCis on AACR in New Orleans

Swedish

English

 

2016 January 19

Oncology Venture – Newsletter

Swedish

English

 

2016 January 18

Oncology Venture reports from Biotech JPMorgan in US

Swedish

English

 

2015 November 17

Peter Buhl Jensen, CEO of Oncology Venture presented at Sedermeradagen in Stockholm

View video presentation

 

2015 November 2-4

Meet Oncology Venture at BIO-Europe, November 2nd-4th 2015, in Munich

Contact: VP Business Development, Claus Deichgräber Mobile: +45 2015 0605 E-mail: cd@oncologyventure.com

 

2015 September 28-30

Meet Oncology Venture at Sachs Associates, 15th Annual Biotech In Europe Forum, 28th – 30th September 2015 Congress Center Basel, Switzerland

Contact: VP Business Development, Claus Deichgräber Mobile: +45 2015 0605 E-mail: cd@oncologyventure.com  

 

2015 September 9-10

Meet Oncology Venture at the Nordic Life Science Days in Stockholm September 9-10

Contact: VP Business Development, Claus Deichgräber Mobile: +45 2015 0605 E-mail: cd@oncologyventure.com

 

2015 September 4

Three abstracts will be presented on the AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics in November 5-9 2015, Hynes Convention Center, Boston, Massachusetts

Abstract Number:  A182
Title: Targeting the topoisomerase 1 enzyme in cancer cells with acquired resistance to SN-38
Session ID: Poster Session A
Session Title: Topoisomerase Inhibitors
Session Date and Time: Friday Nov 6, 2015 12:15 PM – 3:15 PM
Location: Exhibit Hall C-D
Abstract Number:  B71
Title: DEN-50R – establishment of a novel and unique cell line based drug screening platform for cancer treatment
Session ID: Poster Session B
Session Title: Drug Screening
Session Date and Time: Saturday Nov 7, 2015 12:30 PM – 3:30 PM
Location: Exhibit Hall C-D
Abstract Number:  C168
Title: A two stage prospective clinical trial with irofulven treatment targeting a selected subgroup of castration- and docetaxel resistant prostate cancer patients
Session ID: Poster Session C
Session Title: Therapeutic Agents: Biological
Session Date and Time: Sunday Nov 8, 2015 12:30 PM – 3:30 PM
Location: Exhibit Hall C-D

2015 Juli 22

Peter Buhl Jensen talks about Oncology Ventures first day on Aktietorget.se – Radio24syv

Listen here. Only Danish    2015 Juli 10

Peter Buhl Jensen talks about Oncology Venture – Radio24syv’

 

Listen here. Only Danish 

 

 

OV together with MPI was present at this year’s

American Society of Clinical Oncology conference ASCO in Chicago from 28th May – 3rd June.

 

Oncology Venture på Sedermeradagen i Göteborg 2015


Oncology Venture Company Presentation

Download pdf

Oncology Venture in BioCentury

Download pdf